Glucarpidase to combat toxic levels of methotrexate in patients
Jacalyn M GreenDepartment of Biochemistry, Midwestern University, IL, USAAbstract: In January 2012, glucarpidase (Voraxaze®) received approval from the US Food and Drug Administration for intravenous treatment of toxic plasma methotrexate concentrations due to impaired renal clearance. Metho...
Gardado en:
Autor Principal: | |
---|---|
Formato: | Libro |
Publicado: |
Dove Medical Press,
2012-11-01T00:00:00Z.
|
Subjects: | |
Acceso en liña: | Connect to this object online. |
Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|
Internet
Connect to this object online.3rd Floor Main Library
Número de Clasificación: |
A1234.567 |
---|---|
Copia 1 | Dispoñible |